Nanostructures for antimicrobial therapy:
Nanostructures for Antimicrobial Therapy discusses the pros and cons of the use of nanostructured materials in the prevention and eradication of infections, highlighting the efficient microbicidal effect of nanoparticles against antibiotic-resistant pathogens and biofilms. Conventional antibiotics a...
Gespeichert in:
| Format: | Elektronisch E-Book |
|---|---|
| Sprache: | English |
| Schriftenreihe: | Nanostructures in therapeutic medicine series
|
| Schlagworte: | |
| Online-Zugang: | FLA01 Volltext |
| Zusammenfassung: | Nanostructures for Antimicrobial Therapy discusses the pros and cons of the use of nanostructured materials in the prevention and eradication of infections, highlighting the efficient microbicidal effect of nanoparticles against antibiotic-resistant pathogens and biofilms. Conventional antibiotics are becoming ineffective towards microorganisms due to their widespread and often inappropriate use. As a result, the development of antibiotic resistance in microorganisms is increasingly being reported. New approaches are needed to confront the rising issues related to infectious diseases. The merging of biomaterials, such as chitosan, carrageenan, gelatin, poly (lactic-co-glycolic acid) with nanotechnology provides a promising platform for antimicrobial therapy as it provides a controlled way to target cells and induce the desired response without the adverse effects common to many traditional treatments. Nanoparticles represent one of the most promising therapeutic treatments to the problem caused by infectious micro-organisms resistant to traditional therapies. This volume discusses this promise in detail, and also discusses what challenges the greater use of nanoparticles might pose to medical professionals. The unique physiochemical properties of nanoparticles, combined with their growth inhibitory capacity against microbes has led to the upsurge in the research on nanoparticles as antimicrobials. The importance of bactericidal nanobiomaterials study will likely increase as development of resistant strains of bacteria against most potent antibiotics continues |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | 1 online resource |
| ISBN: | 9780323461511 0323461514 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045131343 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 180814s2017 |||| o||u| ||||||eng d | ||
| 020 | |a 9780323461511 |9 978-0-323-46151-1 | ||
| 020 | |a 0323461514 |9 0-323-46151-4 | ||
| 035 | |a (ZDB-33-ESD)ocn988849134 | ||
| 035 | |a (OCoLC)988849134 | ||
| 035 | |a (DE-599)BVBBV045131343 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 082 | 0 | |a 615.7/92 |2 23 | |
| 245 | 1 | 0 | |a Nanostructures for antimicrobial therapy |c editors, Anton Ficai, Alexandru Mihai Grumezescu |
| 300 | |a 1 online resource | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Nanostructures in therapeutic medicine series | |
| 500 | |a Includes bibliographical references and index | ||
| 520 | |a Nanostructures for Antimicrobial Therapy discusses the pros and cons of the use of nanostructured materials in the prevention and eradication of infections, highlighting the efficient microbicidal effect of nanoparticles against antibiotic-resistant pathogens and biofilms. Conventional antibiotics are becoming ineffective towards microorganisms due to their widespread and often inappropriate use. As a result, the development of antibiotic resistance in microorganisms is increasingly being reported. New approaches are needed to confront the rising issues related to infectious diseases. The merging of biomaterials, such as chitosan, carrageenan, gelatin, poly (lactic-co-glycolic acid) with nanotechnology provides a promising platform for antimicrobial therapy as it provides a controlled way to target cells and induce the desired response without the adverse effects common to many traditional treatments. Nanoparticles represent one of the most promising therapeutic treatments to the problem caused by infectious micro-organisms resistant to traditional therapies. This volume discusses this promise in detail, and also discusses what challenges the greater use of nanoparticles might pose to medical professionals. The unique physiochemical properties of nanoparticles, combined with their growth inhibitory capacity against microbes has led to the upsurge in the research on nanoparticles as antimicrobials. The importance of bactericidal nanobiomaterials study will likely increase as development of resistant strains of bacteria against most potent antibiotics continues | ||
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a Anti-infective agents |2 fast | |
| 650 | 7 | |a Nanostructures |2 fast | |
| 650 | 4 | |a Anti-Infective Agents | |
| 650 | 4 | |a Nanostructures | |
| 650 | 4 | |a Anti-infective agents | |
| 650 | 4 | |a Nanostructures | |
| 700 | 1 | |a FICAI, ANTON. |e Sonstige |4 oth | |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 0323461522 |
| 776 | 0 | 8 | |i Erscheint auch als |n Druck-Ausgabe |z 9780323461528 |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780323461528 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-030521338 | ||
| 966 | e | |u http://www.sciencedirect.com/science/book/9780323461528 |l FLA01 |p ZDB-33-ESD |q FLA_PDA_ESD |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804178790807502848 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV045131343 |
| collection | ZDB-33-ESD ZDB-33-EBS |
| ctrlnum | (ZDB-33-ESD)ocn988849134 (OCoLC)988849134 (DE-599)BVBBV045131343 |
| dewey-full | 615.7/92 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.7/92 |
| dewey-search | 615.7/92 |
| dewey-sort | 3615.7 292 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03196nmm a2200445zc 4500</leader><controlfield tag="001">BV045131343</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">180814s2017 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780323461511</subfield><subfield code="9">978-0-323-46151-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0323461514</subfield><subfield code="9">0-323-46151-4</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-33-ESD)ocn988849134</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)988849134</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045131343</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.7/92</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Nanostructures for antimicrobial therapy</subfield><subfield code="c">editors, Anton Ficai, Alexandru Mihai Grumezescu</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Nanostructures in therapeutic medicine series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Nanostructures for Antimicrobial Therapy discusses the pros and cons of the use of nanostructured materials in the prevention and eradication of infections, highlighting the efficient microbicidal effect of nanoparticles against antibiotic-resistant pathogens and biofilms. Conventional antibiotics are becoming ineffective towards microorganisms due to their widespread and often inappropriate use. As a result, the development of antibiotic resistance in microorganisms is increasingly being reported. New approaches are needed to confront the rising issues related to infectious diseases. The merging of biomaterials, such as chitosan, carrageenan, gelatin, poly (lactic-co-glycolic acid) with nanotechnology provides a promising platform for antimicrobial therapy as it provides a controlled way to target cells and induce the desired response without the adverse effects common to many traditional treatments. Nanoparticles represent one of the most promising therapeutic treatments to the problem caused by infectious micro-organisms resistant to traditional therapies. This volume discusses this promise in detail, and also discusses what challenges the greater use of nanoparticles might pose to medical professionals. The unique physiochemical properties of nanoparticles, combined with their growth inhibitory capacity against microbes has led to the upsurge in the research on nanoparticles as antimicrobials. The importance of bactericidal nanobiomaterials study will likely increase as development of resistant strains of bacteria against most potent antibiotics continues</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Anti-infective agents</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Nanostructures</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-Infective Agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanostructures</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Anti-infective agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Nanostructures</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">FICAI, ANTON.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">0323461522</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Druck-Ausgabe</subfield><subfield code="z">9780323461528</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780323461528</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-030521338</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://www.sciencedirect.com/science/book/9780323461528</subfield><subfield code="l">FLA01</subfield><subfield code="p">ZDB-33-ESD</subfield><subfield code="q">FLA_PDA_ESD</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV045131343 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:09:34Z |
| institution | BVB |
| isbn | 9780323461511 0323461514 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-030521338 |
| oclc_num | 988849134 |
| open_access_boolean | |
| physical | 1 online resource |
| psigel | ZDB-33-ESD ZDB-33-EBS ZDB-33-ESD FLA_PDA_ESD |
| publishDateSearch | 2017 |
| publishDateSort | 2017 |
| record_format | marc |
| series2 | Nanostructures in therapeutic medicine series |
| spelling | Nanostructures for antimicrobial therapy editors, Anton Ficai, Alexandru Mihai Grumezescu 1 online resource txt rdacontent c rdamedia cr rdacarrier Nanostructures in therapeutic medicine series Includes bibliographical references and index Nanostructures for Antimicrobial Therapy discusses the pros and cons of the use of nanostructured materials in the prevention and eradication of infections, highlighting the efficient microbicidal effect of nanoparticles against antibiotic-resistant pathogens and biofilms. Conventional antibiotics are becoming ineffective towards microorganisms due to their widespread and often inappropriate use. As a result, the development of antibiotic resistance in microorganisms is increasingly being reported. New approaches are needed to confront the rising issues related to infectious diseases. The merging of biomaterials, such as chitosan, carrageenan, gelatin, poly (lactic-co-glycolic acid) with nanotechnology provides a promising platform for antimicrobial therapy as it provides a controlled way to target cells and induce the desired response without the adverse effects common to many traditional treatments. Nanoparticles represent one of the most promising therapeutic treatments to the problem caused by infectious micro-organisms resistant to traditional therapies. This volume discusses this promise in detail, and also discusses what challenges the greater use of nanoparticles might pose to medical professionals. The unique physiochemical properties of nanoparticles, combined with their growth inhibitory capacity against microbes has led to the upsurge in the research on nanoparticles as antimicrobials. The importance of bactericidal nanobiomaterials study will likely increase as development of resistant strains of bacteria against most potent antibiotics continues MEDICAL / Pharmacology bisacsh Anti-infective agents fast Nanostructures fast Anti-Infective Agents Nanostructures Anti-infective agents FICAI, ANTON. Sonstige oth Erscheint auch als Druck-Ausgabe 0323461522 Erscheint auch als Druck-Ausgabe 9780323461528 http://www.sciencedirect.com/science/book/9780323461528 Verlag URL des Erstveröffentlichers Volltext |
| spellingShingle | Nanostructures for antimicrobial therapy MEDICAL / Pharmacology bisacsh Anti-infective agents fast Nanostructures fast Anti-Infective Agents Nanostructures Anti-infective agents |
| title | Nanostructures for antimicrobial therapy |
| title_auth | Nanostructures for antimicrobial therapy |
| title_exact_search | Nanostructures for antimicrobial therapy |
| title_full | Nanostructures for antimicrobial therapy editors, Anton Ficai, Alexandru Mihai Grumezescu |
| title_fullStr | Nanostructures for antimicrobial therapy editors, Anton Ficai, Alexandru Mihai Grumezescu |
| title_full_unstemmed | Nanostructures for antimicrobial therapy editors, Anton Ficai, Alexandru Mihai Grumezescu |
| title_short | Nanostructures for antimicrobial therapy |
| title_sort | nanostructures for antimicrobial therapy |
| topic | MEDICAL / Pharmacology bisacsh Anti-infective agents fast Nanostructures fast Anti-Infective Agents Nanostructures Anti-infective agents |
| topic_facet | MEDICAL / Pharmacology Anti-infective agents Nanostructures Anti-Infective Agents |
| url | http://www.sciencedirect.com/science/book/9780323461528 |
| work_keys_str_mv | AT ficaianton nanostructuresforantimicrobialtherapy |